Biodistribution and radiation dosimetry of the novel 18F-labeled prostate-specific membrane antigen-ligand PSMA-7 for PET/CT in prostate cancer patients

被引:0
|
作者
Hohberg, Melanie [4 ]
Dietlein, Markus [4 ]
Kobe, Carsten [4 ]
Dietlein, Felix [1 ]
Zlatopolskiy, Boris [3 ]
Krapf, Philipp [2 ]
Wild, Markus [4 ]
Taeger, Philipp [4 ]
Neumaier, Bernd [2 ]
Drzezga, Alexander [4 ]
机构
[1] Dana Farber Canc Inst, Boston, MA USA
[2] Forschungszentrum Julich, Julich, Germany
[3] IREMB, Cologne, Germany
[4] Univ Hosp Cologne, Dept Nucl Med, Cologne, Germany
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
88
引用
收藏
页数:1
相关论文
共 50 条
  • [41] FLUORINE-18 (18F) PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) POSITRON EMISSION TOMOGRAPHY (PET) AND THE DIAGNOSIS AND STAGING OF PRIMARY PROSTATE CANCER (PCA)
    Byrne, Matthew
    Ranasinha, Nithesh
    Mercader, Claudia
    Raslan, Mutie
    Lewis, Francesca
    Gorgoraptis, Stefanos
    Sathanapally, Ganesh
    Vieira, Ana Catarina Lopes
    Jedrzej, Golebka
    Peiris, Bryony
    Tuthill, Mark
    Protheroe, Andrew
    Camilleri, Philip
    Turner, Phil
    Andrade, Gerard
    Miah, Saiful
    Leslie, Tom
    Bryant, Richard
    Hamdy, Freddie
    MacPherson, Ruth
    Gleeson, Fergus
    Lamb, Alastair D.
    JOURNAL OF UROLOGY, 2022, 207 (05): : E881 - E881
  • [42] Fluorine-18 (18F) Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography (PET) and the diagnosis and staging of primary Prostate Cancer (PCa)
    Byrne, M. H., V
    Ranasinha, N.
    Mercader, C.
    Raslan, M.
    Lewis, F.
    Gorgoraptis, S.
    Sathanapally, G.
    Vieira, Lopes A. C.
    Golebka, J.
    Peiris, B.
    Tuthill, M.
    Protheroe, A.
    Camilleri, P.
    Turner, P.
    Andrade, G.
    Miah, S.
    Leslie, T.
    Bryant, R.
    Hamdy, F.
    Macpherson, R.
    Gleeson, F.
    Lopez, F.
    Lamb, A. D.
    EUROPEAN UROLOGY, 2022, 81 : S1105 - S1106
  • [43] Single Lesion on Prostate-specific Membrane Antigen-ligand Positron Emission Tomography and Low Prostate-specific Antigen Are Prognostic Factors for a Favorable Biochemical Response to Prostate-specific Membrane Antigen-targeted Radioguided Surgery in Recurrent Prostate Cancer
    Horn, Thomas
    Kroenke, Markus
    Rauscher, Isabel
    Haller, Bernhard
    Robu, Stephanie
    Wester, Hans Juergen
    Schottelius, Margret
    van Leeuwen, Fijs W. B.
    van der Poel, Henk G.
    Heck, Matthias
    Gschwend, Juergen E.
    Weber, Wolfgang
    Eiber, Matthias
    Maurer, Tobias
    EUROPEAN UROLOGY, 2019, 76 (04) : 517 - 523
  • [44] 64Cu-Labeled Inhibitors of Prostate-Specific Membrane Antigen for PET Imaging of Prostate Cancer
    Banerjee, Sangeeta Ray
    Pullambhatla, Mrudula
    Foss, Catherine A.
    Nimmagadda, Sridhar
    Ferdani, Riccardo
    Anderson, Carolyn J.
    Mease, Ronnie C.
    Pomper, Martin G.
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (06) : 2657 - 2669
  • [45] Prostate specific membrane antigen (PSMA) CT PET imaging in prostate cancer: A revolution in patient care
    Bechar, J.
    Cubas, V.
    Muthuveloe, D. W.
    Doherty, A. P.
    BJU INTERNATIONAL, 2015, 115 : 62 - 62
  • [46] Management impact and detection rate of 18F-Prostate-Specific Membrane Antigen (18F-PSMA) PET/CT imaging for biochemically recurrent prostate cancer
    Panagiotidis, E.
    Paschali, A.
    Klampatsas, A.
    Pipintakou, A.
    Makridou, A.
    Chatzipavlidou, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S174 - S174
  • [47] Cold Kit for Prostate-Specific Membrane Antigen (PSMA) PET Imaging: Phase 1 Study of 68Ga-Tris (Hydroxypyridinone)-PSMA PET/CT in Patients with Prostate Cancer
    Hofman, Michael S.
    Eu, Peter
    Jackson, Price
    Hong, Emily
    Binns, David
    Iravani, Amir
    Murphy, Declan
    Mitchell, Catherine
    Siva, Shankar
    Hicks, Rodney J.
    Young, Jennifer D.
    Blower, Philip J.
    Mullen, Gregory E.
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (04) : 625 - 631
  • [48] PET imaging with of prostate-specific membrane antigen (PSMA) for staging of primary prostate cancer with 68Ga-HBED-PSMA.
    Maurer, Tobias
    Gschwend, Juergen
    Wester, Hans-Juergen
    Souvatzoglou, Michael
    Beer, Ambros
    Holzapfel, Konstantin
    Weirich, Gregor
    Haller, Bernhard
    Kuebler, Hubert
    Schwaiger, Markus
    Eiber, Matthias
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [49] The novel theranostic PSMA-ligand PSMA-617 in the diagnosis of prostate cancer by PET/CT: biodistribution in humans, radiation dosimetry and first evaluation of tumor lesions
    Afshar-Oromieh, A.
    Hetzheim, H.
    Kratochwil, C.
    Benesova, M.
    Eder, M.
    Neels, O.
    Kuebler, W.
    Giesel, F. L.
    Mier, W.
    Kopka, K.
    Haberkorn, U.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S175 - S175
  • [50] Prostate-specific membrane antigen (PSMA)-ligand positron emission tomography and radioligand therapy (RLT) of prostate cancer
    Tateishi, Ukihide
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (04) : 349 - 356